BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10517905)

  • 1. Cell specific effects of glucocorticoid treatment on the NF-kappaBp65/IkappaBalpha system in patients with Crohn's disease.
    Thiele K; Bierhaus A; Autschbach F; Hofmann M; Stremmel W; Thiele H; Ziegler R; Nawroth PP
    Gut; 1999 Nov; 45(5):693-704. PubMed ID: 10517905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of nuclear factor kappa B inflammatory bowel disease.
    Schreiber S; Nikolaus S; Hampe J
    Gut; 1998 Apr; 42(4):477-84. PubMed ID: 9616307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activation of nuclear factor-kappaB and effects of anti-inflammatory treatment thereon in intestinal mucosa of patients with ulcerative colitis].
    Gan H; Ouyang Q; Chen Y; Xia Q
    Zhonghua Yi Xue Za Zhi; 2002 Mar; 82(6):384-8. PubMed ID: 11953203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB.
    Bierhaus A; Schiekofer S; Schwaninger M; Andrassy M; Humpert PM; Chen J; Hong M; Luther T; Henle T; Klöting I; Morcos M; Hofmann M; Tritschler H; Weigle B; Kasper M; Smith M; Perry G; Schmidt AM; Stern DM; Häring HU; Schleicher E; Nawroth PP
    Diabetes; 2001 Dec; 50(12):2792-808. PubMed ID: 11723063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased levels of NF-kappaB inhibitors (IkappaBalpha and IkappaBgamma) in the intestinal mucosa of Crohn's disease patients during infliximab treatment.
    Guidi L; Costanzo M; Ciarniello M; De Vitis I; Pioli C; Gatta L; Pace L; Tricerri A; Bartoloni C; Coppola L; Balistreri P; Doria G; Fedeli G; Gasbarrini GB
    Int J Immunopathol Pharmacol; 2005; 18(1):155-64. PubMed ID: 15698520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal NOD2 expression and NF-kappaB activation in pediatric Crohn's disease.
    Stronati L; Negroni A; Merola P; Pannone V; Borrelli O; Cirulli M; Annese V; Cucchiara S
    Inflamm Bowel Dis; 2008 Mar; 14(3):295-302. PubMed ID: 18092345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfasalazine inhibits activation of nuclear factor-kappaB in patients with ulcerative colitis.
    Gan HT; Chen YQ; Ouyang Q
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1016-24. PubMed ID: 15955209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glimepiride reduces mononuclear activation of the redox-sensitive transcription factor nuclear factor-kappa B.
    Schiekofer S; Rudofsky G; Andrassy M; Schneider J; Chen J; Isermann B; Kanitz M; Elsenhans S; Heinle H; Balletshofer B; Häring HU; Schleicher E; Nawroth PP; Bierhaus A
    Diabetes Obes Metab; 2003 Jul; 5(4):251-61. PubMed ID: 12795658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterisation of decoy receptor 3 in Crohn's disease.
    Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
    Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease.
    Segain JP; Raingeard de la Blétière D; Bourreille A; Leray V; Gervois N; Rosales C; Ferrier L; Bonnet C; Blottière HM; Galmiche JP
    Gut; 2000 Sep; 47(3):397-403. PubMed ID: 10940278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of NF-kappaB and stress-activated protein kinases in steroid unresponsiveness.
    Bantel H; Schmitz ML; Raible A; Gregor M; Schulze-Osthoff K
    FASEB J; 2002 Nov; 16(13):1832-4. PubMed ID: 12223450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammation.
    Monteleone G; Mann J; Monteleone I; Vavassori P; Bremner R; Fantini M; Del Vecchio Blanco G; Tersigni R; Alessandroni L; Mann D; Pallone F; MacDonald TT
    J Biol Chem; 2004 Feb; 279(6):3925-32. PubMed ID: 14600158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25-dihydroxyvitamin D3 inhibits nuclear factor kappa B activation by stabilizing inhibitor IκBα via mRNA stability and reduced phosphorylation in passively sensitized human airway smooth muscle cells.
    Song Y; Hong J; Liu D; Lin Q; Lai G
    Scand J Immunol; 2013 Feb; 77(2):109-16. PubMed ID: 23126502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expressions of NF-κBp65 and IκBα in gestational trophoblastic disease and clinical significance].
    Ju LL; Liu HN; Cai JT; Xu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Oct; 28(10):1084-7. PubMed ID: 23046941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of IkappaBalpha increases the expression of matrix metalloproteinase-2 in human ciliary muscle cells.
    Lan YQ; Zhang C; Xiao JH; Zhuo YH; Guo H; Peng W; Ge J
    Mol Vis; 2009 Sep; 15():1977-87. PubMed ID: 19816602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enalapril inhibits nuclear factor-κB signaling in intestinal epithelial cells and peritoneal macrophages and attenuates experimental colitis in mice.
    Lee C; Chun J; Hwang SW; Kang SJ; Im JP; Kim JS
    Life Sci; 2014 Jan; 95(1):29-39. PubMed ID: 24239644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation.
    Rödel F; Hantschel M; Hildebrandt G; Schultze-Mosgau S; Rödel C; Herrmann M; Sauer R; Voll RE
    Int J Radiat Biol; 2004 Feb; 80(2):115-23. PubMed ID: 15164793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanisms of prednisone inhibition of inflammation in Crohn's disease involve changes in intestinal permeability, mucosal TNFalpha production and nuclear factor kappa B expression.
    Wild GE; Waschke KA; Bitton A; Thomson AB
    Aliment Pharmacol Ther; 2003 Aug; 18(3):309-17. PubMed ID: 12895215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of angiotensin II and aldosterone on NF-kappaB binding activity in hepatic stellate cells].
    Li X; Meng Y; Jiang B; Yang XS; Wang WW; Guo D; Lai ZS; Zhang ZS
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(6):374-80. PubMed ID: 15854525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.